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Background: To determine the correlation of cyclin-dependent kinase inhibitor 1B (p27) expression with
clinicopathologic features in nasopharyngeal carcinoma (NPC), including patient prognosis.
Methods: Real-time PCR and immunohistochemistry were used to examine the mRNA and protein expressions of
p27 in NPC and nasopharyngeal tissues. The relationship of p27 expression levels with clinical features and
prognosis of NPC patients was analyzed.
Results: The expression level of p27 mRNA was markedly lower in NPC tissues than that in the nasopharyngeal
tissues (P = 0.0006). Specific p27 protein staining by immunohistochemistry was found in the nuclei and cytoplasm
of nasopharyngeal and malignant epithelial cells but decreased expression was observed in NPC samples
compared to normal epithelium samples (P = 0.002). In addition, low levels of p27 protein were inversely
correlated with the status of T classification (p = 0.002) and clinical stage (p = 0.019) of NPC patients. Patients with
lower p27 expression had a significantly shorter overall survival time than did patients with high p27 expression.
Multivariate analysis suggested that the level of p27 expression was not an independent prognostic indicator
(p = 0.682) for NPC survival.
Conclusion: Low level of p27 expression is a potential unfavorable prognostic factor for patients with NPC.
Virtual slides: The virtual slide (s) for this article can be found here: http://www.diagnosticpathology.diagnomx.
eu/vs/1915282782109343.
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Nasopharyngeal carcinoma (NPC) is a squamous cell
carcinoma derived from mucosal epithelium of the naso-
pharynx correlated with EBV infection, environmental
factors and genetic aberrance. Among them, EBV infec-
tion is the most important for NPC, when other cancers
in upper digestive tract have something with to do with
it [1]. The initiation and progression of NPC is a com-
plex and consecutive process with the participation of* Correspondence: 29606771@qq.com; 7102981@qq.com
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stated.many important genes [2-5]. In a previous study, we
used cDNA microarray to detect differentially expressed
genes among NPC and nasopharyngeal tissues (NP) and
observed that expression of p27, a gene encoding cyclin-
dependent kinase inhibitor 1B, was indicated to be sig-
nificantly reduced in NPC tissues and cells, hinting its
potentially suppressive role in NPC pathogenesis [6]
(Additional file 1: Figure S1).
P27 is an enzyme inhibitor that in humans is encoded
by the CDKN1B gene. It encodes a protein which belongs
to the Cip/Kip family of cyclin dependent kinase (Cdk)
inhibitor proteins. In previous investigations, down-
expression of P27 had been indicated in many tumor
types, including lung cancer [7], hepatocellular carcinoma
[8], gastric cancer [9], colorectal cancer [10] et al., whichtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Correlation between the clinicopathologic
characteristics and expression of p27 protein in NPC
Characteristics n p27 (n) P
High expression Low expression
Gender
Male 93 49 44
Female 37 13 24 0.082
Age(y)
≥50 62 30 32
<50 68 32 36 1.000
Smoking
Yes 32 21 11
No 98 41 57 0.025
Recurrence
Yes 4 2 2
No 126 60 66 1.000
T classification
T1-T2 90 51 39
T3-T4 40 11 29 0.002
N classification
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tumors. Further, p27 was observed to act as a significant
role in suppressing tumor pathogenesis [11,12]. Based on
the above reports mentioned, p27 was taken as an impor-
tant gene participating in tumor pathogenesis. The role
p27 plays in NPC has also been reported in several refer-
ences [13,14].p27 was found the low expression level
may contribute to the aggressive behavior of NPC by
immunohistochemistry.
To further clarify its role in NPC pathogenesis, the
present study was to investigate the expression status of
mRNA and protein in much more NPC cases and NP
cases than those of the previous literatures, and then
analyze the potential associations of this protein with
clinicopathological features and overall survival rate in
130 cases of NPC patients.
Materials and methods
Cell culture
Seven (7) NPC cell lines including 5-8 F, 6-10B, CNE2,
C666-1, HONE1, HNE1, and SUNE1 were maintained in
RPMI 1640 supplemented with 10% newborn calf serum
(NBCS) (PAA Laboratories, Inc, Austria).N0-N1 73 38 35
N2-N3 57 24 33 0.291
Distant metastasis
Yes 10 5 5
No 129 57 63 1.000
TNM Clinical stage
I~II 49 30 19
III~IV 81 32 49 0.019Sample collection
Sixty-one (61) primary fresh NPC samples and 20 non-
cancerous fresh nasopharyngeal samples were collected at
the time of diagnosis before any therapy at the People’s
Hospital of Zhongshan City, China from 2012 to 2013. All
fresh samples were immediately preserved in liquid nitro-
gen. Thirty-five (35) NP tissues and 130 undifferentiated
NPC paraffin-embedded specimens with clinic and prog-
nosis information from 2003 to 2006 were obtained from
the People’s Hospital of Zhongshan City, and their age
ranging from 21 to 80 years (median, 49.6 years). Brief
clinical data of these NPC cases were given in Table 1. For
the use of these clinical materials for research purposes,
prior consent from the patients and approval from the
Ethics Committees of these two hospitals were obtained.
All specimens had confirmed pathological diagnosis and
were staged according to the 1997 NPC staging system of
the UICC.Real-time PCR
Real-time PCR was used to measure the expression of p27
mRNA in fresh NPC cells, NPC tissues, and NP tissues
using SYBR Premix Ex Taq (Takara, Japan) with an
Mx3000P real-time PCR system (Stratagene, La Jolla, CA,
USA) and the reaction was repeated three times. The
sequence for sense primer was 5′- GAAGCCTGGC
CTCAGAAGAC-3′, and for antisense primer was 5′- TC
CAACGCTTTTAGAGGCAGAT-3′. ARF gene was used
as an internal control [3].Immunohistochemistry
Immunohistochemistry was utilized to examine the
protein expression of p27 with rabbit anti-human p27
antibody (1:100) (Santa Cruz Biotechnology, USA)
according to the previous description [2]. Sections
were visualized with DAB and counterstained with
hematoxylin, mounted in neutral gum, and analyzed
using a bright field microscope.Evaluation of staining
The immunohistochemically stained tissue sections of
p27 in cytoplasm were reviewed and scored separately
by two pathologists blinded to the clinical parameters.
Expression of p27 in the nucleus and in the cyto-
plasm was independently evaluated and scored as pre-
viously described [12]. The sum of the cytoplasm and
nuclear staining scores was used as the final staining
score for p27. For statistical analysis, a final staining
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be low or high expression.
Statistical analyses
All statistical analyses were performed using SPSS
13.0 and Graphpad softwares. Data were presented as
mean ± SD. Two-tailed Student’s t test was used for com-
parisons of 2 independent groups. The χ2 test was used to
analyze the relationship between the levels of p27 expres-
sion and clinicopathologic characteristics. Survival curves
were plotted using the Kaplan-Meier method and com-
pared using the log-rank test. The significances of various
variables in survival were analyzed using multivariate cox
proportional hazards model. A P value of less than 0.05
was considered statistically significant.
Results
P27 mRNA is expressed at low levels in NPC tissue
In order to assess the role of p27 in NPC, we per-
formed real-time PCR to measure the expression of
p27 mRNA transcripts in 61 fresh NPC tissues and
20 fresh collected normal nasopharyngeal tissues.
Compared with normal nasopharyngeal tissues, NPC
cells and tissues showed reduced expression levels
of p27 mRNA (p = 0.0006) (Figure 1A). Furthermore,
decreased p27 mRNA expression was observed in
clinical stage III-IV compared to clinical stage I-II
samples (Figure 1B) (p = 0.0103). However, we did not
find the significantly differential expression of p27
mRNA in T3-4 and N2-3 compared to T1-2 and
N0-1 (Figure 1C, D).Figure 1 Expression of P27 mRNA in NPC tissues and NP tissues. A. m
NP tissues by real-time PCR assay. B. A significant reduction of p27 mRNA e
clinical stage I-II. C,D: Significantly differential mRNA expression of p27 wasImmunohistochemical analysis of p27 protein expression
in NPC and nasopharynx tissues
We measured the expression levels and subcellular
localization of p27 protein in 130 archived paraffin-
embedded NPC samples and 35 NP samples using
immunohistochemical staining (Figure 2A-D). Specific
p27 protein staining was detected in the nuclei and
cytoplasm of non-cancerous and malignant epithelial
cells (Figure 2A, B). Decreased expression of p27 was
observed in NPC samples compared to NP tissues
(P = 0.002) (Table 2).
Relationship between clinicopathological characteristics
and p27 expression in NPC patients
The relationship between clinicopathological charac-
teristics and p27 expression levels in individuals with
NPC is summarized in Table 1. We did not find a
significant association between p27 expression levels
with patient’s age, sex, smoking, disease recurrence, N
classification, and M classification in 130 NPC cases.
However, we observed that the expression level of
p27 was inversely correlated with tumor size (T clas-
sification) (P = 0.002) and clinical stage (I-II vs. III-IV)
(P = 0.019) in NPC patients (Table 1).
Survival analysis
To investigate the prognostic value of p27 expression
for NPC, we assessed the association between the
levels of P27 expression and patients’ survival using
Kaplan–Meier analysis with the log-rank test. In 130
NPC cases with prognosis information, we observedRNA expression of p27 was decreased in NPC tissues compared with
xpression was indicated in NPC clinical stage III-IV compared with
not observed in NPC T3-4 and N2-3 compared with T1-2 and N0-1.
Table 2 Protein expression of p27 between NPC and NP
tissues
Group Protein expression(n) P value
Cases High expression Low expression
NPC 130 62 68
NP tissues 35 27 8 P = 0.002
Figure 2 P27 protein was expressed in the cytoplasm and nuclei of non-cancerous and malignant epithelial cells and its down-regulation
was indicated in NPC tissues compared to NP samples (original magnifications are: Х 100). A shows the strong expression of p27 in normal
epithelium; and in some cases, p27 highly expresses in cytoplasm and nucleus (inset); B displays the high p27 expression in cytoplasm and nuclei
of NPC tissues; C shows the positive cytoplasm p27 expression in NPC tissues; D indicates the negative expression of p27 in NPC tissues.(insets
showing P27 expression observed under high magnification Х 400).
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nificantly correlated with the overall survival of NPC
patients (Figure 3). Patients with high levels of p27
expression had better survival than those with low
levels of P27 expression (P = 0.026). In addition, we
also observed that the patients with higher P27
protein expression had longer survival time N0-N1
(P = 0.011) classification (Figure 4). Univariate analyses
showed that patient survival was also significantly
correlated with radiotherapy, T, N, M classifications,
clinical stages and the expression of p27 (P = 0.005,
P<0.001, P<0.001, P<0.001, P<0.001, and P = 0.032
respectively). To determine whether p27 is an in-
dependent prognostic factor for NPC, we performed
multivariate analysis of P27 protein expression levels
adjusted for age, gender, smoking status, T classi-
fication, N classification, M classification, and clinical
stages of NPC patients. These results showed that the
level of P27 expression was not an independent prog-
nostic factor for NPC (P = 0.682) (Table 3).
Discussion
NPC is a unique malignant head/neck cancer with re-
markably distinctive ethnic and geographic distribu-
tion among the world.Though there are some other
neoplasms such as lymphoma, carcinoma of salivary
gland and rare melanotic disease [15], NPC is themost common in nasopharyngeal region. It is a di-
sease with disorder of cell cycle and uncontrolled
growth due to abnormal expression of cell cycle fac-
tors [4,6,16]. P27, a key cell cycle protein kinase in-
hibitor, formed a complex with CCND1 and CDK4
that prevents CDK4 from adding phosphate residues
to its principal substrate, the retinoblastoma (pRb)
protein and blocks the cell-cycle G1/S transition. Fur-
thermore, p27 is able to bind other Cdk proteins
when it connected to cyclin subunits such as Cyclin
A/Cdk2 and Cyclin E/Cdk2 and suppress the transi-
tion of cell cycle. Decreased expression of p27 has
been indicated in many tumors, including lung cancer
[17], bladder cancer [18], melanoma [19], and ovarian
cancer [20], prostate cancer [21], which was asso-
ciated with the unfavorable clinical parameters and
poor outcomes of these tumors. However, the role of
p27 is still unclear in NPC.
Figure 3 Expression of p27 protein predicts NPC patients’
overall survival time. Patients with high level of p27 expression
had better survival than those with low level of p27 expression.
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cantly attenuated levels of p27 mRNA in NPC tissues
and cells compared to NP tissues [6] by gene micro-
array analysis. In this study, we validated the sig-
nificantly differential expression of mRNA in NPCFigure 4 The correlation of p27 expression with NPC patients’ survival
and M classification. Patients with higher expression of p27 protein indica
other clinical classifications.tissues and NPC cells compared to NP tissues by
real-time PCR. Our reports were similar with the in-
vestigation of p27 mRNA expression in other tumors
[17-19]. Furthermore, we also found that reduced
mRNA p27 expression was shown in clinical stage of
III-IV compared to clinical stage of I-II. These results
preliminarily suggested p27 as a potentially suppressive
gene involved in the pathogenesis of NPC.
In subsequent exploration, we observed that p27
protein was a co-expression factor of cytoplasm and
nucleus in NPC tissues and nearly a half of NPC
cases showed nuclear expression of p27. In line with
the mRNA expression examination, p27 protein ex-
pression was significantly down-regulated in NPC
tissues compared to NP tissues. This result further
provided evidence to support p27 as a candidate sup-
pressor in NPC. Further, we analyzed the correlation
of p27 protein expression with clinical features of
NPC patients. We found that although p27 protein
expression was not associated with patient’s age, sex,
smoking, N classification (lymph node metastasis) or
M classification (distant metastasis), it was positively
correlated with T classification (tumor size) and cli-
nical stage. This result was similar to our report oftime in strata analysis in TNM stage, T classification, N classification,
ted longer survival time only in N0-N1 classification in NPC, but not
Table 3 Summary of Cox regression analysis of overall survival duration of P27 nuclear and cytoplasm expression
Parameter Univariate analysis Multivariate analysis
P HR 95% CI P HR 95% CI
Gender
Male vs. female 0.485 0.488 0.665-2.361
Age
≥50 vs. <50 years 0.787 0.073 0.620-1.881
Family tumor history
Yes vs. No 0.349 0.877 0.000-28.401
Smoking
Yes vs. No 0.387 0.748 0.368-1.474
Chemotherapy
Yes vs. No 0.700 1.153 0.560-2.372
Radiotherapy
Yes vs. No 0.005 0.369 0.184-0.742 0.944 1.032 0.431-2.469
T classification
T1-T2 vs. T3-T4 0.000 13.289 1.884-8.223 0.014 6.032 1.225-6.067
N classification
N0-N1 vs. N2–N3 0.000 2.950 1.662.-5.237 0.240 1.379 0.720-3.700
M classification
M0 vs. M1 0.000 35.042 5.031-24.906 0.001 10.438 1.803-11.112
TNM Clinical stage
I-II vs. III-IV 0.000 19.386 3.592-27.943 0.051 3.795 0.992-14.238
P27 expression
High expression vs. low expression 0.030 4.724 0.290-0.938 0.682 0.168 0.471-1.637
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presented the evidence that protein expression of p27
protein in NPC was inversely correlated with patient’s
overall survival time. Patients with high protein ex-
pression of p27 had an overall longer survival time.
Our results here suggest that p27 protein expression
is taken as a tumor suppressor inhibiting the patho-
genesis of NPC.
Furthermore, survival prognosis was assessed by
stratification analysis against different T classification,
N classification, M classification, and clinical stage.
We observed that p27 protein expression was only
positively associated with the survival time for NPC
patients in N0-1 classification. Patients with high p27
expression had better prognosis than those of nega-
tive nuclear expression. These results hinted that p27
expression is a good biomarker for evaluating the
prognosis of NPC patients with N0-1 classification.
Finally, we evaluate the possibility of p27 protein
expression as an independent prognostic factor. Ac-
cording to univariate analysis, patient’s overall survival
is inversely proportional to T/N/M classification, cli-
nical stage, but positively correlated with p27 proteinexpression and radiotherapy. Multivariate analyses
showed that nuclear expression of p27 protein was
not an independent predictor of prognosis for NPC
patients regardless of its patients’ disease status. This
result was not consistent with the reports from other
tumors including breast cancer [22] and glioma [23]
etc.
In summary, our results provide evidence that
expression of p27 may be involved in the clinical
progression and poor prognosis of NPC patients.
However, it could not serve as a potential indepen-
dent prognostic factor for NPC patients.Conclusion
In summary, our study demonstrated that the expres-
sion level of p27 was significantly reduced in NPC
and correlated with the malignant status and poor
prognosis for NPC patients. Due to the limited sam-
ple size of patients in our investigation, further stud-
ies are needed to verify these findings and establish
the role of p27 as a reliable clinical predictor for the
outcome of NPC patients.
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